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Linda Ryen 
Department of Public Health and Community Medicine, Institute of Medicine 
Sahlgrenska Academy at University of Gothenburg, Sweden 
ABSTRACT 
The aim of this thesis is to analyze the role of health economics for priority 
setting in health care and public health. Four papers provide the basis for the 
analysis. Paper I contains an application of a typical cost-effectiveness 
analysis, where the cost per QALY for an injury prevention strategy is 
assessed. Paper II reviews and analyzes the literature on estimates of the 
willingness to pay for a QALY. Paper III describes the burden of injury 
fatalities both in terms of ‘number of fatalities’ as well as ‘sum of potential 
years of life lost’, to study the priority-setting implications of the different 
metrics. In paper IV, public preferences for priority setting criteria in health 
care are explored based on a population survey.  
Results show that, despite being cost-saving from the societal perspective, 
there is a risk that interventions are not being implemented due to lack of 
incentives when different actors carry costs and enjoy benefits. Reviewing the 
literature on the willingness to pay for a QALY displays a wide spread of the 
estimates, indicating that there is not much hope of finding one monetary value 
of a QALY from the current literature to inform a demand-based threshold 
value in cost-effectiveness analyses. The choice of using life-years lost or 
fatalities (“lives lost”) carries substantial implications for priority setting 
among injury types and must be carefully considered in evaluations of 
interventions. Finally, the survey results on public preferences indicate a 
reluctance to accept any criteria for priority setting, which makes it difficult to 
assess how the criteria actually used by decision-makers align with the 
preferences of the payers (i.e. the population).  
Keywords: prioritizing, preferences, QALY, cost-benefit analysis, cost-utility 
analysis, cost-effectiveness analysis, willingness to pay 
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SAMMANFATTNING PÅ SVENSKA 
Hälso- och sjukvård liksom folkhälsoarbete är nyttigheter som i Sverige 
huvudsakligen finansieras med skattemedel. Eftersom medborgarnas behov av 
och efterfrågan på hälso- och sjukvård är större än vad tillgängliga resurser 
räcker till, är prioritering en nödvändighet. Att prioritera handlar om att 
bestämma vilka behov som ska ges företräde och vilka som får stå tillbaka. 
Hälsoekonomi innebär en tillämpning av nationalekonomisk teori och metod 
på frågor som rör liv och hälsa. Gemensamt för de metoder som används vid 
hälsoekonomiska utvärderingar är att de jämför kostnader och konsekvenser 
av olika alternativ på ett strukturerat sätt. 
Den här avhandlingen syftar till att analysera hälsoekonomins roll för 
prioritering inom hälso- och sjukvård och folkhälsa. Fyra delstudier ligger till 
grund för analysen. Delstudie 1 innehåller en analys av kostnadseffektiviteten 
av en skadeförebyggande åtgärd och fungerar som ett typfall för hur 
hälsoekonomisk utvärdering kan tillämpas som prioriteringsunderlag. Det 
primära utfallet i studien är kostnaden per vunnet kvalitetsjusterat levnadsår 
(QALY). Delstudie 2 omfattar en översikt av litteraturen som skattat 
betalningsviljan för en QALY, vilket kan användas för att avgöra var gränsen 
för kostnadseffektivitet ska dras. I delstudie 3 beskrivs konsekvenserna av att 
skifta perspektiv på bördan av dödsfall till följd av skador: är det primära att 
minimera dödsfall eller förlorade levnadsår? I delstudie 4 undersöks 
allmänhetens preferenser för olika kriterier som kan ligga till grund för 
prioritering i sjukvården med hjälp av en enkätundersökning. 
Resultaten visar att även om åtgärder är kostnadsbesparande på samhällsnivå, 
dvs. att de förbättrar hälsan till en lägre kostnad, finns en risk att de inte införs 
om det är olika aktörer som bär kostnaderna respektive drar nytta av fördelarna. 
Genomgången av betalningsviljan för ett kvalitetsjusterat levnadsår påvisade 
en stor spridning av estimaten, vilket tyder på att det inte finns något större 
hopp att hitta ett monetärt värde som skulle kunna användas som gräns för att 
avgöra vad som är kostnadseffektivt utifrån ett samhällsekonomiskt 
perspektiv. Att skifta fokus från antalet döda till förlorade levnadsår förändrar 
den relativa betydelsen av olika skadetyper. Detta är en aspekt att tänka på vid 
valet av utvärderingsmetodik och utfallsmått. Slutligen indikerar enkät-
resultaten avseende preferenser för prioritering att det tycks finnas en allmän 
motvilja mot att överhuvudtaget prioritera inom sjukvården, vilket gör det svårt 
att avgöra om befolkningens preferenser kring prioriteringar överensstämmer 
med de faktiska prioriteringsgrunder som används. 
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DEFINITIONS IN SHORT 
Health care The organized provision of medical care to 
individuals or a community [1]. This 
includes the maintaining, improving or 
restoring of health by prevention, diagnosis 
and treatment of diseases, injuries or other 
physical and mental impairments which are 
delivered by health professionals [2]. 
Health economics The application of economic theory, models 
and empirical methods to the analysis of 
decision-making by individuals, health care 
providers and governments with respect to 
health and health care [3]. 
Priority setting Deciding who gets what at whose expense 
[4]. In order to control the allocation of 
scarce resources, it is decided which 
beneficial treatments are more important 
than others and which are not important at 
all [5].    
Public health Public health concerns the protection and 
improvement of health of people and their 
communities, including promoting healthy 
lifestyles, researching disease and injury 
prevention, and detecting, preventing and 
responding to infectious diseases [6]. 
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1 INTRODUCTION 
People have different and innumerable wants but resources are scarce and have 
alternative uses. This applies to health care and public health services as well 
as to standard market goods. For example, we can always imagine an 
improvement in the number of patient-staff contact hours in long term care, or 
earlier or more extensive access to new oncology drugs, or a higher number of 
publicly available defibrillators etc. At the same time, the resources needed to 
provide these services (nurses, physicians, physical capital, human capital) are 
in limited supply. This means that available resources will never suffice to 
cover all needs, and that choices and priority setting is inevitable. Obviously, 
some of these choices will involve very difficult decisions [7]. 
As individuals, we are constantly facing choices and setting priorities affecting 
our own health, but numerous choices need to be made collectively. These 
social choices are frequently made by politicians or other decision-makers on 
behalf of the general public, whose risk and well-being as payers and patients 
are affected by decisions made [8]. In reality, the saying “health above all” 
does not apply since we clearly choose to satisfy other wants on a daily basis, 
both as individuals and collectively. For instance, people risk their lives for the 
sake of pleasure, comfort or thrill [9].  
On the most general level, the question is how much resources should be 
devoted to health care and how much should be allocated to other ends. 
Resources spent on improving health cannot be used in other sectors and vice 
versa. This illustrates the core concept of opportunity cost: the cost for using 
resources is the value of their best alternative use, since this is what we need 
to sacrifice when deciding to use them to a specific end. No society is as 
healthy as it could be or wealthy enough to avoid all preventable deaths [10]. 
Once resource allocation is decided on at a general level, choices remain on 
how to distribute these resources within the health sector and, given that 
distribution, decide how they should be used. Many choices ultimately boil 
down to questions of value. Should diseases and/or injuries be treated or 
prevented? Which diseases should have priority? Should we go for treatment 
today or invest in research for finding new cures that might benefit future 
generations? Do we prioritize elderly or children, men or women, aim at 
“saving” lives, life years or improving quality of life? Deciding on what 
services to provide or, often more controversially, not to provide, raise 
questions about values and principles in society in general and more 
specifically regarding health and health care. The choices made and priorities 
Priority setting in health care and public health 
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set will ultimately affect whose lives are saved, which fatalities are prevented 
and which diseases are cured or treated.  
Since the allocation of scarce resources as to best satisfy human wants is the 
definition of the basic economic problem, using health economics to aid 
priority setting in health care and public health follows naturally (at least to 
economists). Some might however shy away from promoting economic 
reasoning of costs and consequences as a tool for making choices within areas 
where decisions, more or less directly, affect mortality and morbidity. On the 
other hand, costs are reminding us that resources have alternative uses, which 
implies that decisions and priority setting in health care and public health will 
always implicitly place monetary estimates on life. From an efficiency and 
ethical perspective, it must be argued that it is better to provide transparent and 
systematic input to decision makers considering costs and consequences due 
to alternative courses of action [11]. 
Health economics can be used as an aid to make more rational choices and to 
use resources efficiently, but it cannot deliver the values or ethics to guide 
difficult decisions. Given the values, health economics can provide useful 
analytical tools, by recognizing the scarcity of resources and allocating them 
as efficiently as possible [10]. 
As will be discussed in the following, there are different forms of economic 
evaluation methods used in health care and public health. These methods allow 
for different conclusions in different decision contexts and are also based on 
different normative assumptions about what we aim to maximize. Hence, 
policy decisions can be viewed as a combination of analysis and values, 
implying that methodology as well as preferences are of importance when 
using health economics to support priority setting in health care and public 
health.  
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2 AIM 
The overarching aim of this thesis is to analyze the role of health economics 
for priority setting in health care and public health. Specifically, implications 
for policy and practice from the normative assumptions made indirectly by 
methodological choices are analyzed.  
To provide a basis for this analysis, paper I starts out with the application of a 
typical cost-effectiveness analysis (CEA), often performed for interventions or 
strategies in health care and public health. The following papers relate to the 
overall aim through questions arising in relation to the application of the 
typical CEA.  
The CEA presents the results in terms of the (incremental) cost per quality-
adjusted life year (QALY) gained, which does not in itself say anything about 
the welfare or efficiency effects of introducing an intervention. In practice, 
results are compared to threshold values to decide whether they should be 
introduced. Paper II studies how much society are willing to pay for a QALY, 
based on a review of the literature on the willingness to pay for a QALY, and 
discusses the possibilities to use such estimates to judge the welfare effects 
from interventions. 
Depending on methodological choices, either lives or life years gained will be 
more important. For the analysis in paper I, the number of gained (quality-
adjusted) life years is what enters the analysis. In paper III, the differences in 
interpretation and priority setting that may arise depending on focusing on 
“saving lives” or “saving life-years” are analyzed. Specifically, the burden of 
injury fatalities is described both in terms of the commonly used metric 
‘number of fatalities’ as well as the ‘sum of potential years of life lost’ (PYLL) 
to study how a change of perspective alters the relative importance of injury 
types. 
By using economic evaluation methods, we strive to allocate resources 
efficiently, implementing cost-effective treatments and interventions to 
maximize the value given the resources. There are however other ways to think 
about priority setting, like fairness or need. The theme for paper IV is to assess 
the public preferences for priority setting criteria used in health care. 
Table 1 contains an overview of the specific aims and methods for each paper. 
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Table 1. Aims and methods of the included papers 
  Aim Methods 
Paper I: Modelling the 
cost-effectiveness of 
impact-absorbing flooring 
in Swedish residential care 
facilities. 
To examine the 
conditions under which 
installing impact-
absorbing flooring is 
cost-effective from a 
societal perspective.  
 
Application of an incremental cost-
effectiveness analysis using a 
Markov decision model.  
Paper II: The willingness 
to pay for a quality adjusted 
life year. A review of the 
empirical literature. 
To test the possibilities of 
finding one monetary 
value for a quality-
adjusted life year to be 
used in health economic 
analyses. 
After reviewing the published 
literature estimating the monetary 
value of quality adjusted life years, 
descriptive statistics as well as 
regression analysis are applied to 
explore the impact of 
methodological differences on 
estimates. 
 
Paper III: From loss of life 
to loss of years. A different 
view on the burden of 
injury fatalities in Sweden 
1972-2014. 
To present the impact of 
changing the way of 
describing the burden of 
injury from number of 
fatalities to the sum of 
potential years of life 
lost. 
By combining life-expectancy 
tables with data on external causes 
of injury, the number of injury 
fatalities are converted to a sum of 
potential years of life lost. Spline 
regression models are then used to 
estimate temporal trends in both 
fatality counts and potential years of 
life lost. 
 
Paper IV: What should 
guide priority setting in 
health care? A study of 
public preferences in 
Sweden. 
 
To explore public 
preferences on age, 
disease severity and 
treatment cost as priority 
setting criteria. 
 
Data from a web survey are 
analysed using multinomial logistic 
regression analysis and one-sample 
proportion tests. 
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3 ECONOMIC EVALUATION METHODS 
3.1 ECONOMICS AND HEALTH 
The economic perspective is based on three fundamental ideas: resources are 
scarce in relation to human wants, available resources have alternative uses 
and different people want different things. Given that, the economic problem 
is how to allocate resources in a way that best satisfies wants [10]. Health care 
and public health interventions are generally not traded on markets, but 
publicly regulated and/or provided, implying that there are no market forces 
achieving an optimal (efficient) allocation of resources [9]. Also, health is of 
particular importance to most of us since good health is a major component of 
our well-being [5]. Hence, there are reasons to study the allocation of 
resources both to and within the health sector.  
Economics can be divided into positive and normative analyses, which has 
been described as a dichotomy, i.e. a distinction between two fundamentally 
different things [12]. Positive economics describes the world as it is and 
normative economics tells how it ought to be. Determining what is is a matter 
of facts, what ought to be will always depend on values and perceptions of 
right and wrong. Within health economics, the positive branch for instance 
deals with explaining (describing) individual health behaviour on the basis of 
micro-economic theory while the normative branch aims at determining 
whether introducing a certain health policy is welfare-improving [9]. Thus, 
economic evaluations, i.e. the comparison of costs and consequences of 
alternative courses of actions, are normative by definition in their prescription 
of preferred courses of action from an economic perspective.  
The line between positive and normative is however not always sharp. The 
aim of normative economics is not necessarily to state what should be done or 
which values should be assigned to things but rather to have an analytical 
function, helping to make clear - describing - what would be the implications 
of using different values or choosing different strategies [13].  
In addition, what appears to be positive (descriptive) analyses, often also 
include normative components. This relates to paper III, where two different 
perspectives of presenting the burden of injury are explored; in terms of the 
mere number of fatalities or by aggregating the sum of potential years of life 
lost. Both perspectives are positive - describing the state of the world based 
on facts - but still resulting in different pictures. A normative part enters due 
to questions arising when comparing these pictures. Should we dedicate 
resources to reduce the number of fatalities due to falls, since falls cause a 
Priority setting in health care and public health 
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high number of fatalities each year? Or should we use resources to reduce the 
number of suicides or poisonings, injury types causing a greater loss in terms 
of life years, since those affected on average are younger? This illustrates how 
values and preferences might affect the health economic evaluation setting: 
should we aim at saving lives or life years? 
3.2 DIFFERENT CHOICES, DIFFERENT 
METHODS 
There are different forms of health economic evaluation methods, sharing a 
common feature: the comparison of benefits to costs resulting from of a health 
policy or intervention. The methods are categorized as cost-benefit (CBA) and 
cost-effectiveness (CEA) analyses [14]. Depending on which type of choice 
we face, different methods allow us to draw different conclusions, which is 
illustrated in figure 1. Paper I contains an application of a typical CEA 
performed on an injury prevention strategy. 
This difference between evaluation methods, in terms of what conclusions 
they allow for, is a rationale for paper II. The search for a monetary value of 
a quality adjusted year (QALY) also implies searching for a link between CEA 
to CBA and a possibility to say something about the welfare economic 
consequences of interventions, i.e. allowing for conclusions about whether 
resources should be allocated to health or used to achieve other goals. 
 
 
Figure 1. Conceptual illustration of the scope of different health economic evaluation 
methods 
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CBA has the potential to say something about whether an intervention is 
worthwhile from a societal perspective, i.e. be an aid in deciding how to 
allocate resources between health and other sectors [11].  
CEA comes in two forms, depending on whether consequences are expressed 
in terms of a composite health metric or in natural units. When health 
consequences (in the most common case) are described in terms of quality-
adjusted life years (QALYs), a generic measure combining effects on length 
of life and quality of life, the CEA is by some authors referred to as cost-utility 
analysis (CUA) [15]. A CUA results in a cost per QALY gained, making 
comparisons of different interventions affecting health across different groups 
of patients or disease areas possible, i.e. allowing for answering the question 
‘health for whom?’. Although still common in the literature, economists 
typically do not prefer to use the term CUA since QALYs are not theoretically 
considered to be proper utilities [11, 16]. 
When a CEA expresses consequences in natural units, the cost of achieving an 
effect, like lowering the cholesterol level or the number of hip fractures 
avoided, is compared between different strategies [14]. This means that only 
interventions resulting in the same type of effectiveness outcome are 
compared, allowing the identification of the most cost effective way to achieve 
a certain result.  
The methods share the same basics: ’to identify, measure, value and compare 
the costs and consequences of the alternatives being considered’ [11]. While 
measuring costs similarly, consequences are dealt with in different ways as 
summarized in table 2. When performing a CBA, all consequences are 
translated into monetary units, allowing for comparisons between different 
areas [14]. CEA and CUA, which are the most commonly used methods within 
the health care and public health sectors, are mainly useful in setting priorities 
and making choices within a given budget or by referring to external standards 
[17]. This will be discussed further in the next section. 
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Table 2. Health economic evaluation methods by costs and consequences 
measured. 
Method Costs Consequences 
Cost-effectiveness 
analysis (CEA) 
 
Monetary units Natural units, the same unit for 
policies compared. 
Cost-utility analysis 
(CUA) 
Monetary units One or multiple effects (not 
necessarily the same for policies 
compared), summarized in a common 
health measure, typically QALYs. 
 
Cost-benefit 
analysis (CBA) 
Monetary units One or multiple effects (not 
necessarily the same for policies 
compared), translated into monetary 
units. 
 
 
3.3 DIFFERENT METHODS, DIFFERENT 
ASSUMPTIONS 
As described in the previous section, there are differences between evaluation 
methods in terms of in which decision context they are useful and how 
consequences are measured or valued. These differences are rooted in the 
normative assumptions underlying the methods, which will be discussed in the 
following.  
3.3.1 CBA AND WELFARISM 
CBA is grounded in welfare economic theory, where the key assumptions are 
that (i) social welfare is a function of the welfare of all individuals and (ii) 
individuals are the best judges of their own welfare [18]. Based on that, all 
policies should be judged by how much utility or welfare they generate, since 
health is only one of many components of people’s welfare. The fact that 
people keep doing things that are not good for their health is seen as proving 
that focusing only on health is not relevant [9, 10].  
The theoretical basis for deciding whether an intervention is increasing social 
welfare or not is the Pareto principle, stating that social welfare increases if 
introducing a policy makes at least one person better off and no one worse off 
[19]. Since that rarely is the case, Hicks and Kaldor reinterpreted the Pareto 
principle to a more practically applicable statement of potential welfare 
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improvement [20, 21]. This means that a policy increases social welfare if 
winners could compensate losers, and still be better off than before 
introducing the policy [22].  
The criterion of potential Pareto improvement forms the basis for CBA, where 
costs and consequences are measured in monetary units and then compared to 
evaluate whether benefits exceed costs. Compensation is hypothetical due to 
an aim of separating the efficiency and equity aspects from each other [23]. 
This means that finding the most efficient way to achieve something is one 
problem, and that equity or distributional concerns should be discussed 
separately.  
One major challenge in performing CBA in health care is to convert health 
outcomes to money. According to welfare economic theory, the value of 
enhanced health is what those gaining from an intervention would be willing 
to give away to achieve the benefits, i.e. their (collective) willingness to pay 
for what is achieved. This willingness to pay resembles the compensation 
criterion of the potential Pareto improvement [24]. It is important to note that 
this money-for-health trade-off should focus on decisions under uncertainty 
[11]. Under scenarios with certainty, individuals might very well demand 
infinite compensation to avoid loss of life, which would make CBA pointless. 
Hence, what is valued is the money-for-health risk trade-off implying that 
values of statistical lives rather than actual lives are used as inputs in CBA. 
The fact that CBA measures and values both costs and benefits in monetary 
terms implies that the decision-rule is relatively straightforward. The net 
present value (NPV) is the outcome of relevance and is calculated as: 
𝑁𝑃𝑉 = ∑ 𝛿𝑡 × (𝐵𝑒𝑛𝑒𝑓𝑖𝑡𝑠 − 𝐶𝑜𝑠𝑡𝑠)𝑡
𝑇
𝑡=0
 
The NPV gives the present value of the difference in benefits and costs of an 
intervention, compared to some relevant comparator, over the life-time (T) of 
the intervention. Often, a discount factor (𝛿 = 1 (1 + 𝑑𝑖𝑠𝑐𝑜𝑢𝑛𝑡 𝑟𝑎𝑡𝑒)⁄ ) is 
also used to adjust benefits and costs that occurs in the future. The potential 
Pareto-criterion states that if the NPV is positive, the intervention increases 
social welfare. 
The fact that all outcomes are measured in monetary units allows informing 
allocation decisions. Decision-makers can assess the return on investments in 
the health sector compared to investments in other sectors of society, thus 
answering the question ‘health or other goals?’. 
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3.3.2 CEA, CUA AND EXTRA-WELFARISM 
CEA, and by definition CUA, is based on the extra-welfarist approach, aiming 
to maximize health (in terms of the greatest number of QALYs or some other 
health metric) according to a given resource allocation [25]. Health itself 
should be maximized, rather than the individual utility to which it may give 
rise. This means that only consequences related to health are considered and 
that the focus is on measuring the cost for achieving a particular health state. 
It also means stepping away from the focus on individual preferences as 
manifested in welfarism, instead applying a more paternalistic perspective in 
deciding that health is the most important goal [18]. 
The QALY concept, which is the most commonly used health outcome in 
CEA/CUA (and will henceforth be used as a generic illustration of the health 
outcome in CEA in this thesis), combines effects on life length with effects on 
quality of life into a single index, thus providing a common currency enabling 
comparisons across different diseases [15]. The strength of QALYs is that it 
captures quality and quantity simultaneously, i.e. changes in morbidity as well 
as mortality [14]. 
The primary outcome of relevance from a CEA is the incremental cost-
effectiveness ratio (ICER). In an example where a new treatment is compared 
to some current treatment, the ICER is calculated as: 
𝐼𝐶𝐸𝑅 = ∑ 𝛿𝑡 ×
(𝐶𝑜𝑠𝑡𝑛𝑒𝑤 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 − 𝐶𝑜𝑠𝑡𝑐𝑢𝑟𝑟𝑒𝑛𝑡 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡)𝑡
(𝑄𝐴𝐿𝑌𝑠𝑛𝑒𝑤 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 − 𝑄𝐴𝐿𝑌𝑠𝑐𝑢𝑟𝑟𝑒𝑛𝑡 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡)𝑡
𝑇
𝑡=0
. 
The ICER is thus the present value of the difference in cost divided by the 
present value of the difference in QALYs, and can be seen as the “price tag” 
(cost) per gained QALY with the new treatment compared to the current 
treatment. 
CEA is useful when health-related quality of life is the important outcome or 
when policies affect both mortality and morbidity, and you need a unit 
combining these effects [11]. This is the case in paper I, where the installation 
of impact-absorbing flooring in residential care facilities is evaluated. Hip 
fractures among the elderly lead to both fatalities as well as pain and suffering, 
meaning that preventing hip fractures affects both mortality and morbidity. 
CEA is also used for comparing policies with different kind of outcomes, 
where a common unit is needed. The way to decide whether an intervention is 
worthwhile from a societal perspective is either to choose interventions in 
ascending order of ICER until the budget is exhausted or to select all 
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interventions with an ICER lower than or equal to a specific threshold value 
[26]. This closely relates to the theme of paper II, as a social monetary value 
of a QALY potentially could be considered a threshold value for deciding on 
which interventions may be defined as cost-effective. 
3.3.3 IMPLICATIONS BY CHOICE OF METHOD 
The primary difference between the methods is the metric used to estimate 
(health) consequences – the monetary willingness to pay or QALYs (or 
something similar to QALYs) [25]. Since both costs and consequences are 
measured in monetary units in CBA, the decision rule is, as described, 
relatively simple: adopt all interventions for which the monetary value of the 
health consequences are greater than the costs (NPV>0).  
Because CEA yields estimates of the cost per gained QALY, the decision rule 
is, as described, somewhat different: adopt all interventions with cost per 
gained QALY (ICER) below some cut-off (threshold) value [26]. The major 
practical advantage of CBA is that it directly answers the question of whether 
or not a policy should be introduced at all [27]. By contrast, CEA takes the 
budget devoted to health for granted, giving no guidance as to how this budget 
is set. 
But, CBA and CEA differ not only technically and in terms of their decision 
rules. Above all, they differ in the incorporation of the welfare of those 
affected. As described in the previous section, CEA focuses on health, CBA 
focuses on utility. They are thus based on different value judgments.  
The welfarist position, underlying CBA, claims that collective decisions 
should be based on the total utility of the affected persons. The extra-welfarist 
position underlying CEA, according to which health is the only relevant 
outcome for particular collective decisions, argues that individual utility is not 
a relevant basis for collective decision-making. This means, that applying 
different methods to the same problem might (and does) yield different results 
[28]. 
It should be stressed, that neither of the methods addresses distributional 
concerns or equity in themselves. CBA takes the present distribution of 
resources for granted and CEA seeks to maximize the number of QALYs from 
a given budget, ignoring who experiences the increase [9].   
More and more CEAs are performed in a wider context than concerning 
medical technologies and health care, for instance in public health, but also in 
social care and regarding environmental regulations affecting health, as 
discussed in paper II. This has its merits, since it allows for comparisons on 
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how health is valued in different sectors – is a QALY gained from treating 
patients with a disease worth more than a QALY gained from public health 
interventions aimed at preventing the same disease? However, if the 
interventions being evaluated can be thought to have broader benefits than just 
pure health effects, there might be a reason to consider performing a CBA 
instead, being able to incorporate a wider range of effects. 
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4 VALUING LIFE AND HEALTH 
Decisions affecting life and health are made regularly, not only by individuals 
but also by parliaments, public authorities and other decision-makers on behalf 
of the public. This involves balancing the protection and lengthening of human 
life against the input of scarce resources [9]. These decisions are not only made 
in health care and public health, but also in other sectors like transportation and 
the environment. Measures that bring benefits usually come with a cost, and 
rational decisions cannot be made unless costs and consequences from the 
specific measures are compared. The fact that such decisions are made, means 
that implicit values for life and health can be estimated, whether it has been 
deliberately taken into account or not. 
Also, it should be pointed out that both valuing health in monetary terms, as in 
the case of CBA, and attaching quality weights for health states, as in CEA, 
are connected with uncertainty and are associated to methodological 
difficulties in obtaining reliable values. 
4.1 VALUING HEALTH OUTCOMES IN 
MONETARY TERMS 
When using CBA, consequences are measured in monetary terms. There are 
three different approaches that have been or are used to assign monetary values 
to health outcomes [11]. Those are the human capital approach, revealed 
preferences (RP) and stated preferences (SP).  
The human capital approach, valuing health in terms of production losses, has 
largely been abandoned for not being compatible to the theoretical foundation 
of welfare economics because of the narrow view of utility as restricted to 
impacts on labor productivity [29]. 
An idea more in line with welfare economics is what those benefitting from an 
intervention are prepared to pay for it. This collective willingness to pay for 
health benefits is the monetary value of health focused on in CBA [11]. The 
value of a statistical life (VSL) is defined as the amount an individual is willing 
to pay for a specified reduction in the probability of death [30]. The reason for 
valuing a statistical life is that the outcome metric should measure the uncertain 
outcome incorporated in health interventions and the monetary value of 
benefits should indicate the value of this probability reduction. 
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Since there are no markets for trading changes in the probability of death (or 
getting ill or injured), there are no market prices available. Thus, monetary 
values are established through RP or SP studies.   
In RP studies, economists try to estimate such values from contexts where 
individuals are trading off risk for money. One such context is the labor market, 
where individuals take on riskier jobs while getting a wage premium in return 
[31]. Another context revealing preferences where risk is traded off for money 
is consumer behavior in connection to products with differing safety features, 
like the willingness to pay for safer cars. There are however difficulties in using 
for instance money-risk trade-offs for estimating the VSL. One problem is that 
people taking risky jobs or buying a new car do not necessarily perceive the 
actual risk level objectively, which of course will distort the resulting estimate. 
SP studies are based on the creation of hypothetical scenarios that respondents 
are asked to value. The most common form is contingent valuation studies 
(CV). Respondents are asked to imagine the contingency of a market for a 
suggested intervention and then state their maximum willingness to pay for 
such an intervention [11]. In choice experiments (CE), respondents are instead 
offered bundles of prices and benefits and are asked to say ‘yes’ or ‘no’ to 
those bundles. Based on repeated choices, this allows for estimating the 
willingness to pay. 
The individuals’ average willingness to pay are then aggregated to a whole 
statistical life and used as a measure of consequences in a CBA. Performing a 
CV to identify the willingness to pay requires a presentation of risk levels, 
which implies that the resulting estimate is related to the risk. In turn, this 
means that a VSL estimate stemming from one risk setting cannot be readily 
transferred to another setting, with different baseline risks [32]. 
4.2 VALUING A QALY 
A number of metrics have been developed in order to summarize the effects of 
health interventions [9]. The best known are probably QALYs and disability-
adjusted life years (DALYs).  
DALYs combine the years of life lost due to disability (premature death) and 
years of life lived with disability [5]. QALYs combine health-related quality 
of life and years of life. Hence, QALYs measure health benefits whereas 
DALYs measure disease burden. Another difference lies in who evaluates 
quality of life. For DALYs, experts make the assessment whereas QALY 
values are based on potential or actual patients. As DALYs are mainly used for 
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international comparisons of disease burden and QALYs are the most common 
metric used in CEA, this section focuses on QALYs. 
QALYs provide a common unit for measuring health benefits by incorporating 
an intervention’s effect on both quality and quantity of life [30]. Using a scale 
where death is assigned 0 and perfect heath is calibrated to the value 1, quality 
weights are multiplied with the time spent in different health states [9]. Hence, 
QALYs represent the number of years in full health that is equivalent to a 
health profile including years of less than full health. 
For CBA, the crucial issue is to value health outcomes in monetary terms. For 
CEA, it is about measuring preferences for different health states and 
converting them to quality weights. There are three techniques being widely 
used: the rating scale, standard gamble and time trade off [11]. In a rating scale, 
respondents are asked to rank health outcomes from the least to the most 
preferred. This is done on a scale where the intervals between outcomes 
indicate the size of the difference in preference. For standard gamble, 
respondents are offered two alternatives. The first alternative is a treatment 
with two possible outcomes: return to full health living for an additional 
number (t) of years with a possibility of p or immediate death with a possibility 
of (1-p). The second alternative is a certain outcome of a chronic state for t 
additional years. The probability of p is then altered until the respondent is 
indifferent between the two alternatives, and p defines the preference score. 
The time trade off technique also offers respondents two alternatives. The first 
alternative is to live in state 1 for time t followed by death. The second 
alternative is to be healthy for time x (less than t) and then die. Time x is then 
altered until the respondent is indifferent between the two alternatives and the 
preference score is indicated by x/t. 
Apart from the difficulty of establishing quality weights capturing differences 
in health states, there is a need to consider who should be asked to judge the 
different health states. In most cases, there will be different results if asking a 
patient population experiencing a certain illness or if asking respondents from 
the general population to imagine the quality of life in hypothetical health 
states. Polsky et al. [33] have for instance shown that quality weights based on 
patient responses were significantly higher than those derived from the general 
population. 
Priority setting in health care and public health 
16 
5 PRIORITY SETTING IN SWEDEN AND 
ABROAD 
The general issue behind priority setting discussions in health care is how to 
balance the demands that demography, technological advances and increased 
public expectations create within the resources available [34].  
Approaches to health care priority setting can be broadly divided into two 
categories; outlining principles to guide priority setting efforts (e.g. Norway, 
the Netherlands, Sweden, and Denmark) or establishing expert bodies to 
recommend what services to provide within the system (e.g. UK, Israel, New 
Zealand and the state of Oregon) [35]. 
In Sweden, parliament has decided on guiding principles by establishing an 
ethical platform [36]. This platform is based on three principles that are 
explicitly ranked: the human value principle takes precedence over the need- 
and solidarity principle which in turn takes precedence over the cost 
effectiveness principle:  
 
(i) The human value principle states that the equal value of all 
human life should be respected and that people have the same 
right to receive health care without consideration of their 
abilities, social status, income, chronological age, ethnicity or 
else.  
(ii) The need and solidarity principle states that those with the most 
pressing medical needs should have more of the health care 
system’s resources than other patient groups and that the needs of 
vulnerable groups and of those who cannot speak for themselves, 
including children and elderly are to be specifically considered. 
(iii) The cost-effectiveness principle implies that the relationship 
between cost and health effects should be reasonable from a 
medical, humanitarian and socioeconomic perspective, allowing 
more people to be treated within a limited budget.  
Health economic research efforts have been devoted to economic evaluation 
of costs and benefits to provide a basis for ranking health care services in terms 
of their relative value for money [37]. However, in many countries there is 
skepticism when it comes to basing priorities on economic criteria, not least 
due to the political and social context in which priority setting is made (ibid). 
The sole use of economic criteria for priority setting implies that overall 
societal health is the only goal when setting priorities but in the publicly 
financed health care, additional objectives in terms of equity and concerns for 
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severity are of interest as well [38]. The principle of equity is a distinct feature 
of health systems in Nordic countries and this principle has been one of the 
main driving forces behind discussions of priority setting [34].  
One way to explain the normative basis in health care priority setting is by 
using theories of distributive justice. Three theories relating to this subject are 
utilitarianism, egalitarianism and maximin [38]. Whereas utilitarianism 
reflects the economic reasoning of maximizing health within a given budget, 
egalitarianism argues for the most equal distribution of resources and the 
maximin theory states that all solutions should be evaluated from the interest 
of the least advantaged, i.e. from a health care perspective the interest of those 
with the most severe conditions. 
There is generally a reluctance to put weight on cost-effectiveness [35]. In both 
Sweden and Denmark, it was specified that cost should only be considered 
when comparing treatments for the same illness [39]. In Sweden, it is however 
being discussed whether the cost-effectiveness principle in reality has been 
given an extended role, allowing for comparisons with threshold values due to 
changes in the law regulating pharmaceutical reimbursements [40, 41]. Only 
New Zealand lists cost-effectiveness as a primary consideration [42]. The UK 
expert body, NICE, explicitly integrates cost in guideline development and 
technology assessment decisions by considering the overall cost of adding a 
new treatment to the existing treatments [43]. 
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6 RESULTS 
In this section, the methods and main results from each paper are summarized. 
For more details, the reader is referred to the appended papers and the more 
general discussion and conclusions are found in section 7 and 8, respectively. 
6.1 MODELLING THE COST-EFFECTIVENESS 
OF IMPACT-ABSORBING FLOORING 
Fall-related injuries, especially hip fractures, among elderly cause morbidity, 
mortality and high costs [44]. As the risk for sustaining fall injuries increases 
with old age and ill-health, those living in residential care facilities are 
especially vulnerable. In paper I, a typical CEA using QALYs as an outcome 
measure, i.e. a CUA as described in section 3.3.2, is performed on the 
installation of impact-absorbing flooring in Swedish residential care facilities. 
Compared to standard flooring, impact-absorbing flooring reduces the force 
transferred to the bone in case of a fall and even small reductions have been 
shown to decrease the number of fractures [45]. Thus, this is a public health 
intervention aimed at preventing injuries.  
6.1.1 METHODS 
The prevention effect considered in the analysis is a decreased probability of 
suffering hip fractures for those living in facilities with impact-absorbing 
flooring. However, as the flooring was rather new at the time of the study, the 
size of this effect was not established. The effect used in the study was thus 
based on laboratory results on the peak force reduction in combination with 
results from the use of hip protectors. The analysis was conducted as a 
modelling study, aiming at exploring the conditions under which the 
intervention is cost-effective from a societal perspective. Data on costs, 
probabilities and quality of life measures were retrieved from the published 
literature and from Swedish register data. A social discount rate of 3 per cent 
was applied and the time horizon was set to a maximum of 10 years due to the 
very small probability of someone living in residential care longer than that, 
given that the average age of entering residential care is 85 years.  
A societal perspective was taken, which implies that all costs and effects are 
considered regardless of who is affected. This further means that consumption 
and production costs were included and because of the age of the target 
population for this particular intervention, the implication is that the cost of 
added life years were taken into account. There is no consensus whether this 
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cost should be included or not [46], and the issue is further discussed in section 
7. 
To estimate the cost-effectiveness of installing impact-absorbing flooring, an 
incremental cost-effectiveness analysis was performed, comparing (the more 
expensive) impact-absorbing flooring to standard flooring in terms of costs and 
QALYs. This means, that the result is expressed as the incremental 
cost/effectiveness ratio (ICER), measuring the difference in costs divided by 
the difference in QALYs resulting from the intervention as shown in the 
formula below. Hence, the result expresses the change in cost resulting from a 
change in QALYs due to the intervention, in most cases that is the cost of one 
additional QALY. 
 (Costimpact-absorbing – Coststandard)/ (QALYimpact-absorbing – QALYstandard)= ΔCost/ΔQALY  
 
To perform the analysis, a Markov cohort model was applied. Markov 
modelling is suitable when the risk is on-going, as is the case here, since every 
individual may suffer zero, one or repeated hip fractures over a number of years 
[7]. A Markov model consists of a finite number of health states depending on 
the intervention at hand. In this case, three different states are included: 
‘healthy’, ‘hip fracture’ and ‘dead’ as shown in figure 2. Every individual 
included will be in one (and only one) of those states at any given time and, 
depending on the transition probabilities entered into the model, individuals 
remain in a state or move to another state.  
 
Figure 2. Markov decision diagram. 
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One cohort enters a care facility with standard flooring and one cohort enters 
a facility with impact-absorbing flooring. In this case, the cohorts will differ 
in terms of the probabilities to move between the states, since the risk for 
suffering a hip fracture is what is affected by the intervention1. 
In each of the states included, for every one-year cycle, QALY estimates (0-
1) and cost estimates are assigned, as well as probabilities for moving between 
states.  
After running the base-case model, a probabilistic sensitivity analysis (PSA) 
by a Monte Carlo simulation was performed. This allows for joint uncertainty 
in all parameters of the model, which is important since the assumptions made 
are crucial for the conclusions, and is a generally recommended approach for 
sensitivity analysis in CEA [47]. Probability distributions are imposed on the 
parameters included in the model, illustrating the uncertainty attached to them 
[7]. The Monte Carlo simulation is then performed by repeatedly running the 
model (in this case, 10,000 times), every time randomly selecting values from 
the distributions assigned to the parameters, and recording the resulting pairs 
of costs and effects. These cost-effect pairs are then used to estimate 
confidence ranges around the results, to illustrate the reliability of the base-
case result. 
6.1.2 RESULTS 
The results indicate that impact-absorbing flooring reduces costs and increases 
QALYs, i.e. that the intervention, under the base-case assumptions, is 
“dominant” (cost-saving and improving health). The average incremental 
saving is SEK 2,786 for 0.02 QALYs. The sensitivity analysis shows that 
installing impact-absorbing flooring is cost-saving in 60 per cent of the 10,000 
iterations made. In another 20 per cent of the iterations, the QALY gain comes 
with a cost, but it is still cost-effective compared to the threshold value of a 
QALY commonly used in Sweden, SEK 500,000 [48]. In 15 per cent of the 
iterations, the ICER is above SEK 500,000 and in the remaining 5 per cent of 
the iterations it is an inferior strategy, i.e. the cost is higher but there is a loss 
of QALYs. 
One-way sensitivity analysis, i.e. altering one parameter at the time, indicate 
that the effectiveness of the impact-absorbing flooring needs to go below 25 
per cent (to be compared to the 60 per cent effectiveness assumed for the base 
case) for the ICER to be over SEK 500,000. Also, doubling the assumed cost 
of the flooring, which could be the result either from higher installation costs 
                                                     
1 When analyzing some other intervention, the difference might as well be in terms of 
costs or effects attached to different states. 
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or due to facilities offering more space per person, yields an ICER of about 
SEK 250,000. Also, the results show that the intervention is dominant and cost-
saving both including and excluding the cost of added life years.  
Paper I illustrates one of the difficulties commonly attached to performing 
CEA on public health interventions, i.e. interventions aimed at preventing 
injuries or illnesses. As previously mentioned, the analysis is performed from 
a societal perspective and the result should be interpreted from that perspective 
as well. In the Swedish setting, most residential care facilities are operated at 
the local level and health care at the regional level. The implication is that the 
cost of installation is carried by one actor and the benefits from the reduction 
in hip fracture costs by another. Thus, the local level lacks the financial 
incentives to install the more expensive flooring.  
Evaluating by the CEA framework, aimed at maximizing health, means that 
non-health effects are not taken into account. In the case of impact-absorbing 
flooring for instance, it has been suggested that the flooring brings (both 
positive and negative) effects for the working environment of nurses at the care 
facilities [49]. Those kinds of effects are not included in paper I. 
Further, interventions aimed at fragile elderly people naturally have a low 
potential for substantial QALY gains since the initial quality of life often is 
low and the remaining life length is short, even in the absence of hip fractures. 
6.2 REVIEWING THE WILLINGNESS TO PAY 
FOR A QALY 
There has been a rapid increase in the use of CEA with QALYs as a health 
outcome measure, like the one performed in paper I, in the evaluation of 
medical technologies as well as public health interventions. As described in 
section 3.3.2, the resulting cost per QALY, i.e. the ICER referred to in section 
6.1, can be compared to alternative interventions or to a specified threshold 
value, thus answering the question ‘health for whom?’ presented in figure 1. 
The question ‘health or other goals?’ can however not be answered unless a 
monetary value could be assigned to a QALY. 
Paper II contains a review of the literature estimating the willingness to pay 
for a QALY, identifying published estimates as well as exploring the impact 
of methodological differences on estimates. 
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6.2.1 METHODS 
The review was based on searches in the databases PubMed, Econlit, and 
Google Scholar using the search terms ‘willingness to pay’, ‘WTP’, ‘value’ 
and ‘monetary value’ in combinations with ‘QALY’, quality-adjusted life 
year’ and ‘life year’. In total, 24 papers met the inclusion criteria: 
 Original and explicit estimates of the willingness to pay 
for a QALY (WTP-Q). 
 Published in peer-reviewed journals in English. 
In those 24 papers, a total of 383 unique estimates were identified. In order to 
render values comparable across time and countries, all estimates were 
converted to 2010 Euros.  
The main methodological difference lies in whether estimates were based on 
stated preference (SP) studies or on VSL-conversions, as described in section 
4.1. In SP studies, respondents are directly asked to state their willingness to 
pay for small health increases/QALYs, and their answers are then transformed 
to estimates on the WTP for a full QALY. For VSL-conversions, the WTP-Q 
is implicitly derived from VSL estimates by assuming a certain life expectancy 
and discount rate for the sample on which the VSL was derived. 
SP-based estimates were more common, and were used in 21 out of 24 studies. 
Estimates also differ in terms of whether the QALYs that respondents are asked 
to value are based on changes in quality of life or on changes in length of life.  
Mean, median and trimmed mean were estimated for the total number of 
estimates and by methodological approach. A logarithmic transformation was 
then performed to adjust for the highly skewed data. Next, linear regression 
analysis was applied examining the impact on the estimates from the 
methodological differences identified in the studies. The factors analyzed 
were: 
 VSL conversions compared to SP studies.  
 Estimates based on length of life changes compared to quality 
of life changes. 
 Size of the change in QALY that respondents were asked to 
value.  
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6.2.2 RESULTS 
The results do not support the existence of one societal monetary value of a 
QALY, due to a wide spread of estimates ranging from less than €1000 to 
€4,800,000. The mean estimate amounts to €118,839 and the trimmed mean, 
i.e. disregarding the 2.5 per cent highest and lowest estimates, respectively, 
amounts to €74,159. The median estimate to €24,226 and about 75 per cent of 
all estimates are below €75,000. 
There are numerous factors to explain the wide range of estimates: studies 
differ in methodology, preferences are elicited in different ways, differences in 
the countries studied, whether the perspective taken is social or individual and 
so on. Several violations of the view that ‘a QALY is a QALY is a QALY’ are 
found since the WTP-Q seems to be related to different contextual factors. This 
is also illustrated by the regression results: 
 It turns out that WTP-Q estimates based on VSL conversions 
are significantly higher than those obtained from SP studies. 
According to the regressions, a WTP-Q estimate that is based 
on a VSL conversion will on average be 5.4 to 7.5 times 
higher than if based on SP studies. 
 When looking at SP studies separately, estimates based on 
changes in life length yield estimates that are 1.4 to 3.5 times 
higher than estimates based on quality of life changes alone.  
 For the cases where the magnitude of the quality of life 
change is explicitly stated in the article, we find that larger 
quality of life changes give lower WTP-Q estimates, i.e. scale 
bias is a problem. 
It is however relevant for decision-makers to have an idea about people’s 
preferences for the allocation of resources, which is the information contained 
in a WTP-based threshold value. If the WTP for a QALY is much higher than 
what can be afforded within a given budget, or the other way around, there is 
reason to think about the allocative efficiency of the economy. The fact that it 
is difficult to achieve a smaller band of values is shared with non-market 
valuation research in general, for example VSL estimations. 
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6.3 FROM LOSS OF LIFE TO LOSS OF YEARS 
As described in section 3.1, the line between positive and normative analyses 
is not as sharp as it might seem. The choice of measure to describe a problem 
will affect how it is perceived in relation to other problems. This may also 
impact priority-setting and economic evaluations. 
The most common way to describe the burden of injury fatalities in a 
population is by simply counting the number of fatalities [50]. But, as a large 
share of fatalities occur in older age-groups, it can be argued that the frequency 
does not fully acknowledge premature mortality as an indicator of the health 
status of a population [51, 52]. Paper III explores the implications of changing 
the perspective in describing the burden of injury fatalities in Sweden, from 
counting the number of fatalities to aggregating the number of potential years 
of life lost (PYLL) due to injuries. In addition, the trends for both measures in 
1972-2014 were studied. This also directly relates to Paper I and II, that focuses 
on life-years (as part of the QALYs), which is the standard approach in CEA. 
6.3.1 METHODS 
The sum of PYLL is defined as the sum of life years lost due to premature 
fatalities from a particular cause in a given population [52]. As each year lost 
is given weight, the implication is that fatalities at young years are valued 
higher than those occurring at old age. There are large differences between 
injury types in terms of the age of the fatalities. In 2014, the average fall fatality 
lost approximately 9 life years while the average poisoning fatality lost 40 
years. 
To calculate the sum of PYLL, it is necessary to estimate the average time a 
person would have lived if the injury had not happened. Here, the remaining 
life expectancy at time of death is used and data is collected from age- and sex 
specific life tables. In combination with injury fatality statistics, the number of 
fatalities is converted to a sum of PYLL, using the below formula, where i=age 
at death, d= number of deaths at age i and Li=life expectancy at age i.  
∑ 𝒅𝒊(𝑳𝒊)
∞
𝒊=𝟎
 
Cause- and group specific spline regression models are then fit to the data in 
order to estimate temporal trends in both the number of fatalities and the sum 
of PYLL for 1972-2014. The fitted values from the regression models are used 
in all calculations to minimize the impact of for example outlier events. 
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6.3.2 RESULTS 
The overall trends for the number of fatalities and the sum of PYLL are similar 
in the time period 1972-2014. There is a steady reduction from the early 1970’s 
to around the year 2000. Since then, both the number of fatalities and sum of 
PYLL increase. 
When comparing the number of fatalities to the sum of PYLL, there are some 
results that deserve to be highlighted:  
 The number of fatalities due to suicides, unknown intent and 
poisonings are increasing whereas other external causes are 
decreasing. This trend is strongly enhanced when studying the 
sum of PYLL, indicating that relatively young people are the 
victims. 
 For both poisonings and suicide, the share of PYLL is larger 
than the share of fatalities, which implies that other factors 
are the driving force behind the increase rather than an aging 
population. 
The results indicate an on-going transition from technical to social injury risks, 
bringing forward new challenges for injury prevention, as behavioural risk 
factors have been shown to be more difficult to handle [53] . 
If it is possible to prevent injury fatalities among young people, i.e. where there 
is a great loss in terms of potential life years, efficient interventions have a 
greater potential to be cost-effective in terms of cost per QALY compared to 
interventions aimed at preventing injuries among older people. However, no 
matter how great the burden of injury from fatalities, there is no escaping the 
necessity to find interventions that really works. 
6.4 PUBLIC PREFERENCES FOR PRIORITY 
SETTING 
Priority setting is to decide who gets what at whose expense [4]. From an 
economic point of view, whose expense relates to the opportunity cost, 
implying that priority setting concerns who will not get health care in order for 
others to have it. In a publicly financed health system, whose expense from a 
financial point of view is the public sector, in other words the tax payers, i.e. 
all of us. Thus, it is reasonable to argue that the criteria used for setting 
priorities should be in line with public preferences. 
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In paper IV, public preferences on priority setting criteria are explored by a 
web survey in the general population in Sweden. Respondents are asked about 
their views on age, treatment costs and disease severity as criteria for setting 
priorities in healthcare.  
6.4.1 METHODS 
In 2014, a web survey was conducted asking respondents to take a stand on 
statements related to priority setting in health care. The data collection was 
performed using a web panel among Swedish residents aged 18 years and 
older. In total, 1,160 respondents answered all of the questions included in this 
study. Respondents were asked to state which claim (out of three) was closest 
to their own opinion of how a health care budget should be distributed. In all 
domains, supporting statement 1 corresponded to agreeing that age, disease 
severity or treatment cost are valid for setting priorities. The statements are 
shown in table 3. 
Table 3. Priority setting statements for respondents 
 
Descriptive summary statistics show that the sample corresponds well to the 
Swedish population in terms of sex and age, but has a higher share of persons 
with university education and a higher net of tax household income. Those 
differences are not uncommon when using web panels [54].  
Age Disease severity Treatment cost
Statement 1: Among patients 
who are equally ill, younger age 
groups should have priority over 
older age groups, since those 
who are younger can be 
supposed to benefit from the 
treatment over a longer period.
Statement 1: Treatment for mild 
diseases should have lower 
priority than treatments for 
severe diseases even if the 
health enhancements are of 
equal size.
Statement 1: Among patients 
who are equally ill, those who 
can be treated at low cost 
should have priority over those 
who can be treated at high cost, 
allowing more people to be 
treated when resources are 
limited.
Statement 2: Priority among 
patients should not depend on 
age.
Statement 2: Priority among 
patients should not depend on 
disease severity.
Statement 2: Priority among 
patients should not depend on 
the cost of treatment, although 
this might mean that fewer 
patients can be treated.
Statement 3: Priority among 
patients should not depend on 
age, unless the remaining life 
span of older patients is very 
short.
Statement 3: Priority among 
patients should not depend on 
disease severity, with exception 
for very mild diseases, which 
should be given lower priority. 
Statement 3: Priority among 
patients should not depend on 
the cost of treatment, unless the 
cost is extremely high.
Which claim is closest to your opinion on how a health budget should be allocated?
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When analysing the collected data, one-sample tests of proportions were 
conducted to test if there was a majority support for the suggested priority 
setting criteria (statement 1). Secondly, those showing weak support (statement 
3) were added and a new one-sample test of proportions was performed. 
Thirdly, the association between individual characteristics like age, sex, level 
of education, and priority setting preferences are analysed by using multi-
nomial logistic regression analysis. This regression analysis methodology is 
suitable when the dependent variable is categorical with more than two levels, 
which was the case here [55].  
6.4.2 RESULTS 
The distribution of answers to the priority setting questions are presented in 
figure 3. A higher share of respondents think that younger individuals should 
not have priority over older ones than the other way around, but a majority are 
prepared to make exceptions if the remaining lifespan for the older person is 
very short. Less than one out of five respondents agree that disease severity 
should guide priority setting in health care. About 50 per cent of respondents 
do however state that severity could be considered if very mild diseases are 
considered. When it comes to treatment costs, 13 per cent agrees that treatment 
costs are valid to use as a priority setting criterion while 41 per cent reject that.  
 
Figure 3. Distribution of answers to the prioritizing questions. Categories 1-3 
corresponds to statements 1-3 in table 2. 
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The results signal a reluctance to priority setting in health care in general, and 
even more so to economic reasoning. It is a limitation of the study that 
respondents were not required to take a stand on how to actually set priorities 
in health care and there is a clear tendency to go for statement 3, which is less 
categorical than statement 1 or 2. However, denying the need for making 
choices is not an option for decision-makers and there seems to be a need to be 
more transparent about the grim reality of priority setting. Further, as 
preferences are divergent, there will always be a need for balancing and 
compromising different interests among groups. As also pointed out by Mason 
et al., there seems to be no set of preferences shared by majorities in 
populations [56].  
It also turns out, that some individual characteristics are clearly related to 
priority setting preferences. There are indications of self-interest, which is not 
surprising, but highlights that there will be trade-offs in priority setting when 
balancing the interests of different groups in the population.  
 Women are less likely than men to agree that treatment costs are 
relevant, to give priority to the young or to treatment of severe 
diseases. 
 Those above 65 years of age are less likely than others to give 
priority to the young and more likely to state that disease severity 
should not be considered when setting priorities. 
 Those younger than 45 years of age are more likely to give priority to 
the young and to severe diseases. 
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7 DISCUSSION 
To recall: the overall aim of this thesis is to look further into the role of health 
economics for priority setting in health care and public health. First, some 
differences regarding the use of health economics for health care and public 
health are discussed, illustrated by paper I. Next, the issues concerning the 
appropriate threshold value for CEA results, the impact of valuing lives or life 
years and the public preferences for priority setting in health care are 
addressed. 
First, it might be useful to consider the differences between the health care and 
public health sectors when using health economic methods. As health 
promotion and prevention efforts compete with health care in the allocation of 
resources, this is an important distinction to address. In health care, people who 
are ill or injured get treated while public health policies are concerned with 
preventing people from getting ill or injured in the first place. In other words, 
public health interventions aim at non-events and resources are invested to gain 
(more or less) uncertain future benefits among (more or less) unidentified 
individuals [57].  
Health care interventions are often more specific in terms of the expected 
outcome: health gain is the one and only effect aimed for and this will be 
captured by QALYs or equivalent metrics. This corresponds to the extra-
welfarist approach underlying CEA. For some public health interventions, this 
works fine as well and CEA is increasingly being used in wider contexts than 
medical technologies and health care. But in many cases, public health 
interventions can be expected to bring a range of outcomes, including non-
health effects that might be realised in a rather distant future compared to most 
health care procedures [57]. These effects might be difficult to incorporate in 
the QALY metric, meaning that the extra-welfarist approach might not be 
suitable since all effects are not included. In those cases, the welfarist 
approach, using CBA, would offer the possibility to capture and include the 
non-health effects. Evaluating by the CEA framework, aimed at maximizing 
health, means that non-health effects are not taken into account. 
CBA is often used for evaluating environmental and transport policies whereas 
CEA/CUA dominates in the health sector [58]. A literature review by 
Buchanan and Wordsworth indicates that applying both methods to same 
problem in many cases leads to different recommendations [28]. This means 
that awareness of the implications by choice of methodology is recommended. 
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A wider use of the same methodology would allow for studying the allocation 
of resources by comparing how much we are prepared to pay for a QALY 
gained within different sectors. This could be interpreted as an indicator of the 
allocative efficiency of the economy. Would resources used to prevent road 
traffic fatalities and injuries save more lives if used in suicide prevention?  
In paper I, installing impact-flooring is a public health intervention where the 
outcome is captured in the QALY metric: decreasing the number of hip 
fractures leads to decreases in mortality and morbidity. However, even in that 
case, non-health effects can be imagined. It has been suggested that the flooring 
brings (both positive and negative) effects for the working environment of 
nurses at the care facilities [49]. 
Economic research with clear results do not always translate into policy [10]. 
This is not necessarily a problem - evaluation outcomes are not substitutes for 
decisions, but rather a way to describe costs and consequences of alternative 
actions which should be considered alongside with values in terms of for 
example equity. Thus, there can be distributional or normative reasons why 
cost-effective policies are considered inappropriate. The results in paper I do 
however highlight another issue in relation to that. Even though the 
intervention was likely to be cost-saving on the societal level, i.e. QALYs are 
gained at a decreased cost, the cost-savings mainly occur in the health care 
sector while the investment costs occur in the long-term care sector 
(municipalities). This may of course reduce the likelihood of the intervention 
being implemented.  
Due to how health care and long term care are organized in Sweden, this is 
probably a common situation when it comes to interventions benefiting frail 
elderly people. This is a dilemma that deserves more thorough consideration. 
Similar situations can arise when it comes to public health interventions that 
are financed by actors outside the health care sector but aiming at effects in 
particular benefiting the health care sector. This could be the case for actors 
within sectors such as school and social services that do not have health as their 
main objective. 
When performing a CBA, willingness to pay estimates for health outcomes are 
used to value benefits in monetary units in order to judge whether an 
intervention is worthwhile from the societal perspective [11]. When 
performing a CEA, knowledge about the appropriate threshold value would 
allow for conclusions about which interventions could be considered to 
increase social welfare.  
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The results in paper I indicated that installing impact-absorbing flooring was 
cost-saving, thus implying that the intervention would increase welfare: there 
would be more health for less resources used. Acknowledging the uncertainty 
of the assumptions, the cost-saving properties remained for 60 per cent of the 
cases whereas another 20 per cent of the cases were below the threshold value 
of SEK 500,000 commonly referred to in Sweden [59]. According to that, there 
was a high possibility that installing the flooring is welfare enhancing. But do 
we know that SEK 500,000 is the appropriate threshold value? 
The review results in paper II did not support the existence of one social value 
of a QALY. Instead, a wide spread of estimates were found. The result further 
implied that estimates obtained from quality of life improvements might not 
be suitable when evaluating policies affecting life length and vice versa. At the 
time of the review, there was a lack of studies combining quality of life and 
length of life changes, which is the relevant case in paper II and in many other 
cases as well. Also, as all estimates in the review were based on hypothetical 
settings, revealed preference studies might be of importance in this field of 
research. Besides from the possibility to identify an appropriate threshold 
level, identifying the willingness to pay for a QALY would be a help to judge 
whether too much or too little resources are allocated to health, thus helping to 
answer the question ‘health or other goals’.  
As described in paper III, every premature death can be considered a social and 
economic loss to society. When counting the number of fatalities, the loss to 
society is considered to be of the same size for each fatality. However, every 
fall fatality in Sweden 2014 resulted in a loss of on average 9 years, whereas 
the average road traffic fatality lost 32 years and the average poisoning fatality 
lost 40 years. As some studies indicate preferences for saving younger lives 
[8], estimating the number of life years lost due to injuries is one way to 
acknowledge that preference. There is no ideal way to measure the burden of 
injury, but it seems wise to combine several measures to provide different 
perspectives [50]. 
The different perspectives, loss of life and loss of years, also relates to the 
choice of methodology in health economic evaluations. In CEA, the number 
of life years saved is part of the QALY metric. This means that interventions 
preventing fatalities among young persons will be more cost-effective than 
interventions preventing fatalities among older persons, all other things equal, 
unless VSL estimates for specific risk settings are established and used. In the 
case of paper I, those living in residential care rarely live more than a few years 
even in the absence of hip fractures. Using the VSL estimate from the 
transportation sector will thus assign very high values to the years gained. The 
results in paper III show that there are quite large differences in age profiles of 
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those affected by different injury types. CEA will be more appropriate for 
evaluation with regard to incorporating those differences, as long as risk-
specific VSL estimates are not available. 
Two central ideas in priority setting with respect to health are benefit 
maximisation and fairness [5]. Benefit maximization requires measurement of 
benefits (for instance, QALYs or in monetary terms) and the use of economic 
evaluation methods like CBA or CEA to identify the most efficient way to 
allocate resources. It might be useful to think about fairness as a constraint on 
the maximisation of benefits. However, there is no generally accepted 
definition of fairness and what is considered fair depends on the values and 
preferences in the population. For instance, is it fairer to give everyone an equal 
share of resources available or to aim at equal outcomes? 
Many people are uncomfortable with the idea of setting priorities regarding 
health, which is indicated in paper IV and in other studies [60]. But whatever 
we might feel about it, the fact is that resources are scarce and that some kind 
of rationing or priority setting will take place anyhow. In order to gain 
acceptance for priority setting and rationing in health care, the criteria used 
need to be in line with public preferences [61]. If there is a general reluctance 
to priority setting in health care, as indicated in paper IV, this can make it more 
difficult to identify true preferences for priority setting criteria. In an open 
discussion of these issues, however, the implications of priority setting need to 
be faced: if there are diseases or patient groups with high priority there will 
inevitably be others with low priority. Paper IV further indicated that costs are 
not considered to be a valid priority setting criteria. Ironically, the fact that 
resources are scarce does however imply that this avoidance of cost 
considerations might be increasingly difficult to retain in practice. 
However, one limitation in paper IV was that respondents were not obliged to 
take a stand on how to actually set priorities. Respondents were allowed to 
disagree with all criteria without stating an alternative. Qualitative studies 
making trade-offs more explicit might be one way to explore preferences more 
thoroughly. A recent study on preferences for health care priority setting in 
nine countries (including Sweden) indicated that multiple factors need to be 
considered in order to reflect population preferences, and that differences seem 
to be country-specific [56]. This means that studies might not be directly 
transferable between countries. 
One question, related to paper I, concerns whether the so-called cost of added 
life years should be included when evaluating interventions. Cost of added life 
years is the net cost (production minus consumption) for people living longer 
due to the intervention at hand. The implication is, that when saving 
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individuals beyond their productive years, there is an extra cost arising. This is 
true from a purely economic perspective, but of course a much more delicate 
question from a normative perspective. What standpoint you take might 
depend on what role you consider economic evaluations to have. If you think 
they tell you exactly what should be done, including the cost of added life years 
probably appears ethically doubtful. On the other hand, considering economic 
evaluations as one of many bases for decision, it would be odd not to clearly 
report all economic consequences – and apply values judgements separately.  
There are sometimes ethical objections to economic reasoning in the health 
domain. However, one might refer to the sixth section of the Helsinki 
declaration, since it specifically points out the significance of evaluation [62]. 
As resources are limited, it is of great importance to use them efficiently. In 
some cases, health economists could benefit from stressing that performing 
economic evaluations actually is in line with the Helsinki declaration. As 
valuing lives and discussing cost-effectiveness in health care sometimes is 
considered somewhat hardhearted, it can be useful to highlight that using 
scarce resources wisely in itself is beneficial for society.  
Health economics has multiple possible roles in terms of priority setting in 
health care and public health. It can be used to describe the need to set priorities 
and the consequences of priority setting, performing economic evaluations to 
draw conclusions about what should be done and also, identifying value 
judgments needed to take a stand on. Economic evaluations are not a substitute 
for decisions, but rather a way to describe costs and consequences of 
alternative actions which should be considered together with values in terms 
of for example equity. Hence, knowledge about preferences is also needed for 
decision-making. 
One important strength of using health economics as an aid in the priority 
setting process, is the systematic framework and array of concepts available in 
general economic theory, concepts that are especially relevant to the choices 
facing policy-makers [10]. Policy depends on analysis and values. Sensitivity 
to that interaction will make economists more useful contributors to health 
policy. Given the values, health economics can be a useful analytical tool, by 
recognizing the scarcity of resources and allocating them as efficiently as 
possible.  
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8 CONCLUSIONS 
 The mere fact that interventions are cost-effective – or even cost-
saving - from the societal perspective does not mean that they are 
always implemented. This is especially the case for public health 
interventions where different actors are carrying costs and enjoying 
the benefits. The incentive structure would need to be altered to 
change this condition. 
 A high burden, whether in terms of lives or life years lost, does not in 
itself mean that there are savings waiting to be realized unless there 
are cost-effective interventions. However, high burdens indicate 
problems where there might be a potential to find such interventions. 
Problems causing a great loss of potential years of life further indicate 
an increased possibility for a lower cost per QALY, due to the fact 
that a high quantity of life years might be saved. 
 Public preferences for priority setting are crucial as resources used by 
public actors are resources stemming from taxes paid by the public. 
The results in paper IV do however indicate a reluctance to priority 
setting which might make it more difficult to find out true preferences 
for the hard choices involved in priority setting. 
 Although the same methods often are applied to both health care and 
public health measures, there are differences that might affect the 
choice of methods and comparison of results. 
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9 FUTURE PERSPECTIVES 
There are opportunities for using health economics to improve the allocation 
of resources to and within the health care and public health sectors. The need 
for priority setting is increasing because of a growing pressure on the health 
system, for instance due to demography and technological advances. At the 
same time, there are indications of a reluctance to priority setting in general 
and to economic reasoning in specific. Hence, it would be valuable to perform 
a qualitative study on preferences for priority setting, exploring whether the 
negative attitudes to economic reasoning is persistent even when inevitable 
trade-offs are made clearer. 
Health economic evaluations can also be used to shed light on the allocative 
efficiency of the economy. In cases where the same methodology is used, 
results can be compared to see whether there are differences in what we are 
prepared to pay for health in within different sectors. If there are significant 
differences, are those in line with public preferences? 
There is also a need to discuss the incentives for performing public health 
interventions in cases where different actors pay and benefit from interventions 
that are cost-effective on the societal level. This is especially relevant in the 
Swedish setting due to the regional organization of health care. 
Finally, although not being a health economic issue, the worrying trend in 
suicides and poisonings, specifically for young men, identified in paper III, 
needs to be addressed.  
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